Sylvain Raoul Simeni Njonnou
Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon; Dschang District Hospital, Dschang, Cameroon
Fernando Kemta Lekpa
Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon
Eric Balti Vounsia
Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon; Douala General Hospital, Douala, Cameroon
Jaures Arnaud Noumedem Kenfack
Department of Physiological Sciences and Biochemistry, University of Dschang, Dschang, Cameroon
Christian Ngongang Ouankou
Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon; Yaoundé University Teaching Hospital, Yaoundé, Cameroon
Diomede Noukeu Njinkui
The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon; Department of Pediatrics, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; Douala GynaecoObstetric and Paediatric Hospital, Douala, Cameroon
Dominique Enyama
The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon; Department of Pediatrics, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; Douala GynaecoObstetric and Paediatric Hospital, Douala, Cameroon
Michel Noubom
Dschang District Hospital, Dschang, Cameroon; Department of Microbiology, Haematology and Immunology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon
Simeon Pierre Choukem
Department of Internal Medicine and Specialties, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon; The University of Dschang Taskforce for the Elimination of COVID-19 (UNITED#COVID-19), Dschang, Cameroon; Douala General Hospital, Douala, Cameroon; Health and Human Development (2HD) Research Network, Douala, Cameroon
Abstract
The coronavirus disease 2019 (COVID-19) has become one of the most tendentious diseases of the 21st century, responsible for more than 2,600,000 deaths worldwide since its declaration in Wuhan (province of Wubei, China) by the end of December 2019. The risk of thrombosis has been described as one of the most prominent features of COVID-19. However, the recommendations for therapeutic anticoagulation are addressed only for severe forms. A recent increase of sudden death in ambulatory patients with COVID-19 in Cameroon prompted us to discuss the possibility to move to anticoagulation for all patients with COVID-19. Thus, we suggest preventive anticoagulation for 14 days for mild forms of COVID-19. For moderate to critical forms, anticoagulation at a curative dose for at least 30 days, and up to 6 months in cases of pulmonary embolism, confirmed or with a high probability. Thus, large-scale randomized clinical trials with indisputable designs are needed.
